Research has found a new combination of drugs could help women with breast cancer live nearly twice as long without the disease progressing, in a "potentially transformative" breakthrough ...
Bristol Myers Squibb posted better-than-expected third-quarter earnings on Thursday citing strong sales of established drugs like blood thinner Eliquis and cancer treatment Revlimid as well as newer ...